Found: 51
Select item for more details and to access through your institution.
Genomics of the NF-κB signaling pathway: hypothesized role in ovarian cancer.
- Published in:
- 2011
- By:
- Publication type:
- journal article
HLA-A2-restricted T-cell epitopes specific for prostatic acid phosphatase.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 6, p. 943, doi. 10.1007/s00262-010-0820-6
- By:
- Publication type:
- Article
Identification of a broad coverage HLA-DR degenerate epitope pool derived from carcinoembryonic antigen.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 1, p. 161, doi. 10.1007/s00262-009-0738-z
- By:
- Publication type:
- Article
CD4 regulatory T cells in human cancer pathogenesis.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 3, p. 271, doi. 10.1007/s00262-006-0194-y
- By:
- Publication type:
- Article
Adoptive T cell therapy of solid cancers.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 1, p. 96, doi. 10.1007/s00262-005-0706-1
- By:
- Publication type:
- Article
The Epitope Integration Site for Vaccine Antigens Determines Virus Control While Maintaining Efficacy in an Engineered Cancer Vaccine.
- Published in:
- Molecular Therapy, 2013, v. 21, n. 5, p. 1087, doi. 10.1038/mt.2013.52
- By:
- Publication type:
- Article
77286 Intravital microscopy in the study of the tumor vasculature of patients with peritoneal carcinomatosis.
- Published in:
- 2021
- By:
- Publication type:
- Abstract
4071 Dynamic Control of Tumor Vessels Augments Antitumor Responses.
- Published in:
- 2020
- By:
- Publication type:
- Abstract
Therapeutic vaccines for malignant brain tumors.
- Published in:
- Biologics: Targets & Therapy, 2008, v. 2, n. 4, p. 753
- By:
- Publication type:
- Article
Cytokine and neuropeptide levels are associated with pain relief in patients with chronically painful total knee arthroplasty: a pilot study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Retraction Note: Targeted immune therapy of ovarian cancer.
- Published in:
- 2016
- By:
- Publication type:
- Erratum
Targeted immune therapy of ovarian cancer.
- Published in:
- Cancer & Metastasis Reviews, 2015, v. 34, n. 1, p. 53, doi. 10.1007/s10555-014-9540-2
- By:
- Publication type:
- Article
Immune cells are increased in normal breast tissues of BRCA1/2 mutation carriers.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 197, n. 2, p. 277, doi. 10.1007/s10549-022-06786-y
- By:
- Publication type:
- Article
Cytotoxic T cell depletion with increasing epithelial abnormality in women with benign breast disease.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 180, n. 1, p. 55, doi. 10.1007/s10549-019-05493-5
- By:
- Publication type:
- Article
CD56+ immune cell infiltration and MICA are decreased in breast lobules with fibrocystic changes.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 167, n. 3, p. 649, doi. 10.1007/s10549-017-4558-0
- By:
- Publication type:
- Article
Immune cell quantitation in normal breast tissue lobules with and without lobulitis.
- Published in:
- Breast Cancer Research & Treatment, 2014, v. 144, n. 3, p. 539, doi. 10.1007/s10549-014-2896-8
- By:
- Publication type:
- Article
Human tumour vessel heterogeneity in ovarian cancer and its association with response to neoadjuvant chemotherapy.
- Published in:
- Clinical & Translational Medicine, 2024, v. 14, n. 4, p. 1, doi. 10.1002/ctm2.1633
- By:
- Publication type:
- Article
Generation of HER2-specific antibody immunity during trastuzumab adjuvant therapy associates with reduced relapse in resected HER2 breast cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Arachidonic acid-induced down-regulation of protein kinase C δ in beta-cells.
- Published in:
- Journal of Cellular Biochemistry, 1996, v. 62, n. 4, p. 543, doi. 10.1002/(SICI)1097-4644(19960915)62:4<543::AID-JCB11>3.0.CO;2-G
- By:
- Publication type:
- Article
Regulation of distinct pools of protein kinase C δ in beta cells.
- Published in:
- Journal of Cellular Biochemistry, 1996, v. 60, n. 1, p. 130, doi. 10.1002/(SICI)1097-4644(19960101)60:1<130::AID-JCB15>3.0.CO;2-T
- By:
- Publication type:
- Article
Dynamic control of tumor vasculature improves antitumor responses in a regional model of melanoma.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-70233-5
- By:
- Publication type:
- Article
The Ratios of CD8<sup>+</sup> T Cells to CD4<sup>+</sup>CD25<sup>+</sup> FOXP3<sup>+</sup> and FOXP3<sup>-</sup> T Cells Correlate with Poor Clinical Outcome in Human Serous Ovarian Cancer.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0080063
- By:
- Publication type:
- Article
Functional Folate Receptor Alpha Is Elevated in the Blood of Ovarian Cancer Patients.
- Published in:
- PLoS ONE, 2009, v. 4, n. 7, p. 1, doi. 10.1371/journal.pone.0006292
- By:
- Publication type:
- Article
Beneficial Effect of TRAIL on HIV Burden, without Detectable Immune Consequences.
- Published in:
- PLoS ONE, 2008, v. 3, n. 8, p. 1, doi. 10.1371/journal.pone.0003096
- By:
- Publication type:
- Article
Immune checkpoint inhibition by anti‐PDCD1 (anti‐PD1) monoclonal antibody has significant therapeutic activity against central nervous system lymphoma in an immunocompetent preclinical model.
- Published in:
- British Journal of Haematology, 2018, v. 183, n. 4, p. 674, doi. 10.1111/bjh.15009
- By:
- Publication type:
- Article
Optimizing patient derived mesenchymal stem cells as virus carriers for a Phase I clinical trial in ovarian cancer.
- Published in:
- Journal of Translational Medicine, 2013, v. 11, n. 1, p. 1, doi. 10.1186/1479-5876-11-20
- By:
- Publication type:
- Article
Optimizing patient derived mesenchymal stem cells as virus carriers for a phase I clinical trial in ovarian cancer.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Vaccination with a plasmid DNA encoding HER-2/neu together with low doses of GM-CSF and IL-2 in patients with metastatic breast carcinoma: a pilot clinical trial.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Vaccination with a plasmid DNA encoding HER-2/ neu together with low doses of GM-CSF and IL-2 in patients with metastatic breast carcinoma: a pilot clinical trial.
- Published in:
- Journal of Translational Medicine, 2010, v. 8, p. 53, doi. 10.1186/1479-5876-8-53
- By:
- Publication type:
- Article
The Microbiome of Aseptically Collected Human Breast Tissue in Benign and Malignant Disease.
- Published in:
- Scientific Reports, 2016, p. 30751, doi. 10.1038/srep30751
- By:
- Publication type:
- Article
Combinatorial Immunoprofiling in Latent Tuberculosis Infection. Toward Better Risk Stratification.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Combinatorial Immunoprofiling in Latent Tuberculosis Infection.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2015, v. 192, n. 5, p. 605, doi. 10.1164/rccm.201412-2141OC
- By:
- Publication type:
- Article
Combinatorial immunoprofiling in latent tuberculosis infection: Toward better risk stratification.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2015, v. 192, n. 5, p. E1, doi. 10.1164/rccm.201412-2141oc
- By:
- Publication type:
- Article
A pilot trial of intravital microscopy in the study of the tumor vasculature of patients with peritoneal carcinomatosis.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-84430-3
- By:
- Publication type:
- Article
Immune response profiling in early rheumatoid arthritis: discovery of a novel interaction of treatment response with viral immunity.
- Published in:
- Arthritis Research & Therapy, 2013, v. 15, n. 6, p. 1, doi. 10.1186/ar4389
- By:
- Publication type:
- Article
Downregulation of TAP1 and TAP2 in early stage breast cancer.
- Published in:
- PLoS ONE, 2017, v. 12, n. 11, p. 1, doi. 10.1371/journal.pone.0187323
- By:
- Publication type:
- Article
Breast cancer vaccines: maximizing peptide-based vaccines by regulatory T cell depletion and toll-like receptor 9 activation.
- Published in:
- 2007
- By:
- Publication type:
- Abstract
Tumor Escape and Progression under Immune Pressure.
- Published in:
- Clinical & Developmental Immunology, 2012, p. 1, doi. 10.1155/2012/641079
- By:
- Publication type:
- Article
Regulatory T cells, inherited variation, and clinical outcome in epithelial ovarian cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 12, p. 1495, doi. 10.1007/s00262-015-1753-x
- By:
- Publication type:
- Article
Immune responses and disease biomarker long-term changes following COVID-19 mRNA vaccination in a cohort of rheumatic disease patients.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1224702
- By:
- Publication type:
- Article
HER-2/neu antigen loss and relapse of mammary carcinoma are actively induced by T cell-mediated anti-tumor immune responses.
- Published in:
- European Journal of Immunology, 2007, v. 37, n. 3, p. 675, doi. 10.1002/eji.200636639
- By:
- Publication type:
- Article
Protein kinase Cι mediates immunosuppression in lung adenocarcinoma.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 671, p. 1, doi. 10.1126/scitranslmed.abq5931
- By:
- Publication type:
- Article
Resistance to Trastuzumab.
- Published in:
- Cancers, 2022, v. 14, n. 20, p. 5115, doi. 10.3390/cancers14205115
- By:
- Publication type:
- Article
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.
- Published in:
- Nature Medicine, 2004, v. 10, n. 9, p. 942, doi. 10.1038/nm1093
- By:
- Publication type:
- Article
Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity.
- Published in:
- Nature Medicine, 2003, v. 9, n. 5, p. 562, doi. 10.1038/nm863
- By:
- Publication type:
- Article
GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells.
- Published in:
- Breast Cancer Research & Treatment, 2010, v. 123, n. 1, p. 39, doi. 10.1007/s10549-009-0622-8
- By:
- Publication type:
- Article
Emergence of immune escape variant of mammary tumors that has distinctproteomic profile and a reduced ability to induce “danger signals”.
- Published in:
- Breast Cancer Research & Treatment, 2006, v. 96, n. 3, p. 243, doi. 10.1007/s10549-006-9163-6
- By:
- Publication type:
- Article
Emergence of immune escape variant of mammary tumors that has distinct proteomic profile and a reduced ability to induce “danger signals”.
- Published in:
- Breast Cancer Research & Treatment, 2006, v. 96, n. 3, p. 233, doi. 10.1007/s10549-005-9044-4
- By:
- Publication type:
- Article
Next generation of immune checkpoint therapy in cancer: new developments and challenges.
- Published in:
- Journal of Hematology & Oncology, 2018, v. 11, p. 1, doi. 10.1186/s13045-018-0582-8
- By:
- Publication type:
- Article
Cancer immunotherapy beyond immune checkpoint inhibitors.
- Published in:
- Journal of Hematology & Oncology, 2018, v. 11, p. 1, doi. 10.1186/s13045-017-0552-6
- By:
- Publication type:
- Article